Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' POSNER J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 50 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Estrada, RD; Posner, J
      The watershed as an organizing principle for research and development: An evaluation of experience in the Andean Ecoregion

      MOUNTAIN RESEARCH AND DEVELOPMENT
    2. Posner, J
      The Consortium for Sustainable Development in the Andean Ecoregion (CONDESAN)

      MOUNTAIN RESEARCH AND DEVELOPMENT
    3. Posner, J
      Anticonvulsant-induced suppression of IFN-gamma production by lymphocytes obtained from cervical lymph nodes in glioma-bearing mice - Comment

      JOURNAL OF NEURO-ONCOLOGY
    4. Shumow, L; Vandell, DL; Posner, J
      Risk and resilience in the urban neighborhood: Predictors of academic performance among low-income elementary school children

      MERRILL-PALMER QUARTERLY-JOURNAL OF DEVELOPMENTAL PSYCHOLOGY
    5. Lieberman, FS; Odel, J; Hirsh, J; Heinemann, M; Michaeli, J; Posner, J
      Bilateral optic neuropathy with IgG kappa multiple myeloma improved after myeloablative chemotherapy

      NEUROLOGY
    6. Cohen, MI; Gaynor, JW; Ramesh, V; Karl, TR; Steven, JM; Posner, J; Clark, BJ; Rhodes, LA
      Extracorporeal membrane oxygenation for patients with refractory ventricular arrhythmias

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    7. Posner, J
      Anti-Yo and anti-Hu

      LABORATORY MEDICINE
    8. Klamt, JG; Posner, J
      Effects of lamotrigine on pain-induced chemo-somatosensory evoked potentials

      ANAESTHESIA
    9. LICHT A; POSNER J; LEIPZIGER LS
      MEDIAN CLEFT-LIP WITH ASSOCIATED MIDLINE SINUSES

      The Journal of craniofacial surgery
    10. PECK RW; WOOTTON R; WIGGS R; LAYTON G; POSNER J
      EFFECT OF FOOD AND GENDER ON THE PHARMACOKINETICS OF TUCARESOL IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    11. SOULLAWTON JH; WEATHERLEY BC; POSNER J; LAYTON G; PECK RW
      LACK OF INTERACTION BETWEEN VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, AND DIGOXIN

      British journal of clinical pharmacology
    12. BRADLEY WG; DAUBE J; MENDELL JR; POSNER J; RICHMAN D; TROOST BT; SWIFT TR
      QUALITY IMPROVEMENT IN NEUROLOGY RESIDENCY PROGRAMS - REPLY

      Neurology
    13. PECK RW; SEABER EJ; DIXON RM; LAYTON GR; WEATHERLEY BC; JACKSON SHD; ROLAN PE; POSNER J
      THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/

      Clinical pharmacology and therapeutics
    14. SHUMOW L; VANDELL DL; POSNER J
      PERCEPTIONS OF DANGER - A PSYCHOLOGICAL MEDIATOR OF NEIGHBORHOOD DEMOGRAPHIC CHARACTERISTICS

      American journal of orthopsychiatry
    15. Mercer, AJ; Lamb, RJ; Rolan, PE; Gibbens, M; Posner, J
      Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteers

      PSYCHOPHARMACOLOGY
    16. SEABER EJ; GILLOTIN C; MOHANLAL R; LAYTON G; POSNER J; PECK R
      LACK OF INTERACTION BETWEEN PIZOTIFEN AND THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS

      Clinical drug investigation
    17. DIXON RM; MEIRE HB; EVANS DH; WATT H; ON N; POSNER J; ROLAN PE
      PERIPHERAL VASCULAR EFFECTS AND PHARMACOKINETICS OF THE ANTIMIGRAINE COMPOUND, ZOLMITRIPTAN, IN COMBINATION WITH ORAL ERGOTAMINE IN HEALTHY-VOLUNTEERS

      Cephalalgia
    18. PECK RW; SEABER EJ; DIXON R; GILLOTIN CG; WEATHERLEY BC; LAYTON G; POSNER J
      THE INTERACTION BETWEEN PROPRANOLOL AND THE NOVEL ANTIMIGRAINE AGENT ZOLMITRIPTAN (311C90)

      British journal of clinical pharmacology
    19. SEABER E; ON N; DIXON RM; GIBBENS M; LEAVENS WJ; LIPTROT J; CHITTICK G; POSNER J; ROLAN PE; PECK RW
      THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90)

      British journal of clinical pharmacology
    20. HUSSEIN Z; POSNER J
      POPULATION PHARMACOKINETICS OF LAMOTRIGINE MONOTHERAPY IN PATIENTS WITH EPILEPSY - RETROSPECTIVE ANALYSIS OF ROUTINE MONITORING DATA

      British journal of clinical pharmacology
    21. DIXON R; GILLOTIN C; GIBBENS M; POSNER J; PECK RW
      THE PHARMACOKINETICS AND EFFECTS ON BLOOD-PRESSURE OF MULTIPLE DOSES OF THE NOVEL ANTIMIGRAINE DRUG ZOLMITRIPTAN (311C90) IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    22. WOOTTON R; SOULLAWTON J; ROLAN PE; SHEUNG CTCF; COOPER JDH; POSNER J
      COMPARISON OF THE PHARMACOKINETICS OF LAMOTRIGINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    23. ROLAN PE; MERCER AJ; TATE E; BENJAMIN I; POSNER J
      DISPOSITION OF ATOVAQUONE IN HUMANS

      Antimicrobial agents and chemotherapy
    24. BECKER GE; EPSTEIN R; COASE R; MILLER M; POSNER J
      THE ROUND-TABLE DISCUSSION

      The University of Chicago law review
    25. GLICKSMAN A; FERDER M; CASALE P; POSNER J; KIM R; STRAUCH B
      1457 YEARS OF MICROSURGICAL EXPERIENCE

      Plastic and reconstructive surgery
    26. SEABER EJ; RIDOUT G; LAYTON G; POSNER J; PECK RW
      THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (ZOMIG 311C90) HAS NO CLINICALLY SIGNIFICANT INTERACTIONS WITH PARACETAMOL OR METOCLOPRAMIDE

      European Journal of Clinical Pharmacology
    27. BRADLEY WG; DAUBE J; MENDELL JR; POSNER J; RICHMAN D; TROOST BT; SWIFT TR
      QUALITY IMPROVEMENT IN NEUROLOGY RESIDENCY PROGRAMS - REPORT OF THE QUALITY IMPROVEMENT COMMITTEE OF THE ASSOCIATION OF UNIVERSITY PROFESSORS OF NEUROLOGY

      Neurology
    28. DEBONY F; BIDAULT R; ALTMAN C; BOIGE V; MARCELLIN P; TRINCHET JC; POSNER J
      LAMOTRIGINE PHARMACOKINETICS IN SUBJECTS WITH LIVER-CIRRHOSIS

      Clinical pharmacology and therapeutics
    29. HOFMANN M; NAHASS D; LANDSBERG L; CARSON L; FELIPE M; GLEW C; SUAREZ M; POSNER J
      THE EFFECTS OF A MULTIDISCIPLINARY GERIATRIC ASSESSMENT TEAM ON HOSPITAL LENGTH OF STAY

      Journal of the American Geriatrics Society
    30. LEVIN MC; FOLEY S; FLERLAGE N; BERK J; ROSENFELD M; DALMAU J; POSNER J; JACOBSON S
      AUTOANTIBODIES PRODUCED BY PATIENTS WITH HTLV-I-ASSOCIATED MYELOPATHYTROPICAL SPASTIC PARAPARESIS REACT EXCLUSIVELY WITH NEURONS - IMPLICATIONS FOR IMMUNE-MEDIATED DAMAGE TO THE CNS IN RETROVIRAL-ASSOCIATED NEUROLOGICAL DISEASE

      Annals of neurology
    31. DIXON RM; MEIRE HB; LEIGH C; POSNER J; ROLAN PE
      EVALUATION OF NONINVASIVE TECHNIQUES TO ASSESS VASOCONSTRICTION IN HEALTHY-VOLUNTEERS USING METHOXAMINE AS A PROBE DRUG

      Cephalalgia
    32. DAVIS JD; DIXON R; KHAN AZ; TOON S; ROLAN PE; POSNER J
      ATOVAQUONE HAS NO EFFECT ON THE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY MALE-VOLUNTEERS

      British journal of clinical pharmacology
    33. SEABER E; ON N; PHILLIPS S; CHURCHUS R; POSNER J; ROLAN P
      THE TOLERABILITY AND PHARMACOKINETICS OF THE NOVEL ANTIMIGRAINE COMPOUND 311C90 IN HEALTHY MALE-VOLUNTEERS

      British journal of clinical pharmacology
    34. LEROY F; GODIN M; LEGALLICLER B; FILLASTRE JP; BIDAULT R; POSNER J; PECK RW
      PHARMACOKINETICS OF NETIVUDINE IN HEMODIALYSIS-PATIENTS

      Journal of antimicrobial chemotherapy
    35. FILLASTRE JP; GODIN M; LEGALLICIER B; CHRETIEN P; BIDAULT R; GILLOTIN C; WOOTON R; POSNER J; PECK RW
      PHARMACOKINETICS OF NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS DRUG, IN PATIENTS WITH RENAL IMPAIRMENT

      Journal of antimicrobial chemotherapy
    36. DEBONY F; BIDAULT R; PECK R; POSNER J
      LACK OF INTERACTION BETWEEN VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, AND MAALOX ANTACID

      Journal of antimicrobial chemotherapy
    37. SMITT PS; MANLEY G; DALMAU J; POSNER J
      THE HUD PARANEOPLASTIC PROTEIN SHARES IMMUNOGENIC REGIONS BETWEEN PEMPSN PATIENTS AND SEVERAL STRAINS AND SPECIES OF EXPERIMENTAL-ANIMALS/

      Journal of neuroimmunology
    38. DIXON R; POZNIAK AL; WATT HM; ROLAN P; POSNER J
      SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF A NOVEL MICROFLUIDIZED SUSPENSION OF ATOVAQUONE IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS

      Antimicrobial agents and chemotherapy
    39. LEVIN MC; BERK J; DALMAU J; ROSENFELD M; FLERLAGE N; POSNER J; JACOBSON S
      PATIENTS WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE I-ASSOCIATED MYELOPATHY TROPICAL SPASTIC PARAPARESIS PRODUCE ANTIBODIES THAT REACT WITH NEURONS

      Neurology
    40. PECK R; WIGGS R; CALLAGHAN J; WOOTTON R; CROME P; FRASER I; FRICK L; POSNER J
      INHIBITION OF DIHYDROPYRIMIDINE DEHYDROGENASE BY 5-PROPYNYLURACIL, A METABOLITE OF THE ANTI-VARICELLA ZOSTER VIRUS AGENT NETIVUDINE

      Clinical pharmacology and therapeutics
    41. ARYA R; ROLAN PE; WOOTTON R; POSNER J; BELLINGHAM AJ
      TUCARESOL INCREASES OXYGEN-AFFINITY AND REDUCES HEMOLYSIS IN SUBJECTSWITH SICKLE-CELL-ANEMIA

      British Journal of Haematology
    42. HOFMANN M; OREILLY L; POSNER J
      TUBERCULOSIS TESTING POLICIES IN PENNSYLVANIA NURSING-HOMES

      Journal of the American Geriatrics Society
    43. ROLAN PE; MERCER AJ; WOOTTON R; POSNER J
      PHARMACOKINETICS AND PHARMACODYNAMICS OF TUCARESOL, AN ANTISICKLING AGENT, IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    44. PECK RW; WOOTTON R; LEE DR; JACKSON SHD; POSNER J
      THE BIOAVAILABILITY AND DISPOSITION OF 1-(BETA-D-ARABINOFURANOSYL)-5-(1-PROPYNYL)URACIL (882C87), A POTENT, NEW ANTI-VARICELLA ZOSTER VIRUSAGENT

      British journal of clinical pharmacology
    45. HARRY JD; BABER N; POSNER J
      HIV SCREENING IN HEALTHY-VOLUNTEERS

      British journal of clinical pharmacology
    46. SOULLAWTON J; SEABER E; ON N; WOOTTON R; ROLAN P; POSNER J
      ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, FOLLOWING ORAL-ADMINISTRATION TO HUMANS

      Antimicrobial agents and chemotherapy
    47. PECK RW; WEATHERLEY BC; WOOTTON R; CROME P; HOLDICH TAH; POSNER J
      PHARMACOKINETICS AND TOLERABILITY OF SINGLE ORAL DOSES OF 882C87, A POTENT, NEW ANTI-VARICELLA-ZOSTER VIRUS AGENT, IN HEALTHY-VOLUNTEERS

      Antimicrobial agents and chemotherapy
    48. PECK RW; WIGGS R; POSNER J
      THE TOLERABILITY, PHARMACOKINETICS AND LACK OF EFFECT ON PLASMA-CHOLESTEROL OF 447C88, AN ACYLCOA-CHOLESTEROL-ACYL-TRANSFERASE (ACAT) INHIBITOR WITH LOW BIOAVAILABILITY, IN HEALTHY-VOLUNTEERS

      European Journal of Clinical Pharmacology
    49. ROLAN PE; MERCER AJ; WEATHERLEY BC; HOLDICH T; MEIRE H; PECK RW; RIDOUT G; POSNER J
      EXAMINATION OF SOME FACTORS RESPONSIBLE FOR A FOOD-INDUCED INCREASE IN ABSORPTION OF ATOVAQUONE

      British journal of clinical pharmacology
    50. MANLEY G; WONG E; DALMAU J; ELKON K; POSNER J; FURNEAUX H
      SERA FROM SOME PATIENTS WITH ANTIBODY-ASSOCIATED PARANEOPLASTIC ENCEPHALOMYELITIS SENSORY NEURONOPATHY RECOGNIZE THE RO-52K ANTIGEN

      Journal of neuro-oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 11:42:59